InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Brennan Aoife, 董事. Insider active across 3 companies, notably FIBROGEN INC. Aggregated, 9 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €30k. History available since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Brennan Aoife
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
68,750 股Common StockSEC:0001193125-26-291131:0
30,902 股Common StockSEC:0001193125-26-291131:1
68,750 股Common StockSEC:0000950170-25-092284:0
8,289 股0Common StockSEC:0001209191-23-036080:0
19,042 股@ US$0.575833.6% 占其流量Common StockSEC:0000899243-23-010715:0
15,777 股0Common StockSEC:0001209191-22-038603:0
8,894 股@ US$2.44590.15% mcap100.0% 占其流量Common StockSEC:0000899243-22-014110:0
106,920 股0Common StockSEC:0000899243-22-005213:0
4,700 股0Common StockSEC:0001209191-21-036668:0
9 条申报中的 9 条
About Brennan Aoife
Aoife Brennan is a Director at FibroGen Inc and Synlogic, Inc. She brings valuable expertise in the biotechnology and healthcare sectors. As a board member, Aoife plays a key role in the governance of the companies, participating in strategic decision-making that influences their direction and performance. Her experience in the sector enables her to contribute to discussions on innovation and the development of new treatments, thereby strengthening the companies' market position.
